NOWDiagnostics
Jody D. Berry serves as the Chief Scientific Officer at NOWDiagnostics (NOWDx) since March 2024, focusing on developing innovative rapid tests for infectious diseases. Previously held the position of CSO and Senior Vice President of Research and Development Innovation at Aspira Women's Health, where advanced multiparameter tests for Ovarian Cancer and Endometriosis were developed. Berry's extensive background includes leadership roles such as Chief Scientific Officer at OraSure Technologies, where the InteliSwab was created, and Director of Research at Grifols, focusing on immunochemistry. Berry has an academic history as an adjunct and assistant professor at the University of Manitoba, mentoring graduate students and conducting significant research in immunology. Educational qualifications include a Ph.D. in Medical Microbiology from the University of Manitoba and a postdoctoral fellowship in Molecular Biology from Scripps Research.
This person is not in any teams
This person is not in any offices
NOWDiagnostics
NOWDiagnostics® Inc. is a leader in innovative diagnostics testing. Its ADEXUSDx® product line features a lab at your fingertip, using only a single drop of blood to test for a variety of common conditions, illnesses and diseases with results in a matter of minutes.